Long-term bone marrow cultured stromal cells regulate myeloma tumour growth in vitro: Studies with primary tumour cells and LTBMC-dependent cell lines

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 166-175

  Bloem, Andries C ^a   Lamme, Tanja ^a   De Smet, Martin ^a   Kok, Henriette ^a   Vooijs, Wim ^a   Wijdenes, John ^b   Boom, Saskia E ^a   Lokhorst, Henk M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Diaclone   (France)

Author keywords

Growth; IL 6; Myeloma; Plasma cell; Stromal cells

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CELL CULTURE; CELL INTERACTION; GROWTH REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; TUMOR GROWTH;

BASE SEQUENCE; BONE MARROW CELLS; CELL DIVISION; CELLS, CULTURED; CLUSTERIN; COMPLEMENT INACTIVATOR PROTEINS; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; MULTIPLE MYELOMA; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 0031983022     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00517.x     Document Type: Article

References (45)

1. Ahsmann, E.J.M., Lokhorst, H.M., Dekker, A.W. & Bloem, A.C. (1992) Lymphocyte function antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood, 79, 2068-2075.
2. Anderson, K.C., Jones, R.M., Morimoto, C., Leavit, P. & Barut, B.A. (1989) Response patterns of purifield myeloma cells to hematopoietic growth factors. Blood, 73, 1915-1924.
3. Barillé, S., Collette, M., Bataille, R. & Amiot, M. (1995) Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood, 86, 3151-3159.
4. Bataille, R., Jourdan, M., Zhang, X.G. & Klein, B. (1989) Serum levels of IL-6, a potent myeloma growth factor, reflect disease activity in plasma cell dyscrasias. Journal of Clinical Investigation, 84, 2008-2011.
5. Bloem, A.C., Chand, A., van Camp, B., Bast, E.J.E.G. & Ballieux, R.E. (1988) Phenotypic and functional characterization of the idiotypic blood B cells in multiple myeloma. Scandinavian Journal of Immunology, 28, 791-797.
6. Choitha C., Lesk, A.M., Tramontano, A., Levitt, M., Smith, G.S., Air, G., Sheriff, S., Padlan, E.A., Davies, D., Tulip, W.R. Colman, P.M., Spinelli, S., Alzari, P.M. & Poljak, R.J. (1989) Conformations of immunoglobulin hypervariable regions. Nature, 342, 877-883.
7. Clement, C., Vooijs, W.C., Klein, B. & Wijdenes, J. (1995) B-B2 and B-B4 two new moab against secreting plasma cells. Leucocyte Typing V (ed. by S. F. Schlossman et al), Vol. 1, pp. 714-715. Oxford University Press.
8. DeGrassi, A., Hilbert, D.M., Rudikoff, S., Anderson, A.O., Potter, M. & Coon, H.G. (1993) In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proceedings of the National Academy of Sciences of the United States of America, 90, 2060-2064.
9. Durie, B.G. (1992) Cellular and molecular genetic features of myeloma and related disorders. Hematology/Oncology Clinics of North America, 6, 463-477.
10. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-846.
11. Ebeling, S.B., Schutte, M.E.M., Akkermans-Koolhaas, K.E., Bloem, A.C., Gmelig-Meyling, F.H.J. & Logtenberg, T. (1992) Expression of members of the immunoglobulin VH3 gene family is not restricted at the level of individual genes in human chronic lymphocytic leukemia. International Immunology, 4, 313-320.
12. Gaillard, J.P., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T. & Klein, B. (1993) Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. European Journal of Immunology, 23, 820-824.
13. Horiuchi, S., Koyanagi, Y., Zhou, Y., Miyamoto, H., Waki, M., Matsumoto, A., Yamamoto, M. & Yamamoto, N. (1994) Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. European Journal of Immunology, 24, 1945-1948.
14. Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., Kuramoto, A. & Kishimoto, T. (1988) Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature, 332, 83-85.
15. Kawano, M., Mihara, K., Huang, N., Tsujimoto, T. & Kuramoto, A. (1995) Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood, 85, 487-494.
16. Kawano, M., Tanaka, H., Ishikawa, H., Nobuyoshi, M., Iwato, K., Sasoku, H., Tanabe, O. & Kuramoto, A. (1989) Interleukin 1 accelerates autocrine growth of myeloma cells through interleukin 6 in human myeloma. Blood, 73, 2145-2148.
17. Kishimoto, T., Akira, S., Narazaki, M. & Taga, T. (1995) Interleukin-6 family of cytokines and gp1 30. Blood, 86, 1243-1254.
18. Klein, B. (1995) Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma. Seminars in Hematology, 32, 4-19.
19. Klein, B., Wijdenes, J., Zhang, X.G., Jourdan, M., Boiron, J.M., Brochier, J., Liautard, J., Merlin, M., Clement, C., Morel-Fournier, B., Lu, Z.Y., Mannoni, P., Sany, J. & Bataille, R. (1991) Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood, 78, 1198-1204.
20. Klein, B., Zhang, X.G., Jourdan, M., Boiron, J.M., Portier, M., Lu, Z.Y., Wijdenes, J., Brochier, J. & Bataille, R. (1990) Interleukin-6 is the central tumour growth factor in vitro and in vivo in multiple myeloma. European Cytokine Network, 1, 193-198.
21. Klein, B., Zhang, X.G., Jourdan, M., Content, J., Houssiau, J.C., Aarden, L., Piechazyck, M. & Bataille, R. (1989) Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by IL-6. Blood, 73, 517-526.
22. Klein S.C., van Wichen, D.F., Golverdingen, J.K., Jacobse, K.C., Broekhuizen, R. & de Weger, R.A. (1995) An improved, sensitive, non-radioactive in situ hybridisation method for the detection of cytokine mRNAs. APMIS, 103, 345-353.
23. Kohayashi, M., Tanaka, J., Imamura, M., Maeda, S., Iwasaki, H., Tanaka, M., Tsudu, Y., Sakurada, K. & Miyazaki, T. (1993) Up-regulation of IL-6 receptors by IL-3 on a plasma cell leukaemia cell line which proliferates dependently on both IL-3 and IL-6. British Journal of Haematology, 83, 535-538.
24. Korholz, D., Nussbaum, P., Pafferath, B., Mauz, C., Hempel, L. & Burdach, S. (1994) Activation of protein kinase C induced de novo synthesis of the soluble interleukin-6 receptor in human B cells. Scandinavian Journal of Immunology, 40, 515-520.
25. Lichtenstein, A., Berenson, J., Norman, D., Chang, M.P. & Carlile, A. (1989) Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood, 74, 1266-1273.
26. Lichtenstein, A., Tu, Y., Vescio, R. & Berenson, J. (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells. Cellular Immunology, 162, 248-255.
27. Lokhorst, H.M., Boom, S.E., Bast, E.J.E.G. & Ballieux, R.E. (1986) Determination of the plasma cell labelling index with bromodeoxyuridine in a double immunofluorescence technique. British Journal of Haematology, 64, 271-275.
28. Lokhorst, H.M., Boom, S.E., Bast, B.J.E.G., Peters, P.J., Tedder, T.F., Gerdes, J., Petersen, E. & Ballieux, R.E. (1987) Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern. Journal of Clinical Investigation, 79, 1401-1411.
29. Lokhorst, H.M., Lamme, T., de Smet, M., Klein, S., de Weger, R.A., van Oers, R. & Bloem, A.C. (1994) Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood, 84, 2269-2277.
30. Martin, S.J., Reutelingsperger, C.P.M., McGahon, A.J., Rader, J.A., van Schie, R.C.A.A., LaFace, D.M. & Green, D.R. (1995) Early distribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl-2 and abl. Journal of Experimental Medicine, 182, 1545-1556.
31. Merico, F., Bergui, L., Gregoretti, M.G., Ghia, P., Aimo, G., Lindley, I.J.D. & Caligaris-Cappio, F. (1993) Cytokines involved in the progression of multiple myeloma. Clinical and Experimental Immunology, 92, 27-31.
32. Nachbauer, D.M., Herold, M., Manesch, A. & Huber, H. (1991) Serum levels of IL-6 in MM and other haematological disorders: correlation with disease activity and other prognostic parameters. Annals of Haematoloyg, 62, 54-58.
33. Nilsson, K., Bennich, H., Johansson, S.G. & Ponten, J. (1970) Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clinical and Experimental Immunology, 7, 477-489.
34. Portier, M., Rajzbaum, Guang Ahang, X., Attal, M., Rusalen, C., Wijdenes, J., Mannoni, P., Maraninchi, D., Piechaczyk, M., Bataille, R. & Klein, B. (1991) In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma. European Journal of Immunology, 21, 1759-1762.
35. Schwarze, M.M. & Kawley, R.G. (1995) Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin-6 mediated up-regulation of bcl-xL. Cancer Research, 55, 2262-2265.
36. Scibienski, R.J., Paglieroni, T., Caggiano, V., Lemongello, D., Gumerlock, P.H. & Mackenzie, M.R. (1992) Factors affecting the in vitro evolution of a myeloma cell line. Leukemia, 6, 940-947.
37. Suzuki, H., Yasukawa, K., Saito, T., Goitsuka, K., Hasegawa, A., Ohsugi, Y., Taga, T. & Kishimoto, T. (1992) Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. European Journal of Immunology 22, 1989-1993.
38. Uchiyama, H., Barut, B.A., Mohrbacher, A.F., Chauhan, D. & Anderson, K.C. (1993) Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood, 82, 3712-3720.
39. van Horssen, M., Loman, S., Rijkers, G.T., Boom, S.E. & Bloem, A.C. (1995) Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling. European Journal of Immunology, 25, 154-158.
40. van Riet, I., de Greef, C., Woischwill, C., de Waele, M., Bakkus, M., Lacor, P., Schots, R. & van Camp, B. (1997) Establishment and characterization of a human stroma-dependent myeloma cell line (MM5.1) and its stroma-independent variant (MM5.2). Leukemia, 11, 284-293.
41. Wijdenes, J., Heinrich, P.C., Muller-Newen, G., Roche, C., Gu, Z., Clement, C. & Klein, B. (1995) Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. European Journal of Immunology, 25, 3474-3481.
42. Yasukawa, K., Futatsugi, K., Saito, T., Yawata, H., Narazaki, M., Susuki, H., Taga, T. & Kishimoto, T. (1992) Association of recombinant soluble IL-6 signal transducer, gp130, with a complex of IL-6 and soluble IL-6 receptor, and establishment of and ELISA for soluble gp130. Immunology Letters, 31, 123-130.
43. Zhang, X., Bataille, R., Jourdan, M., Saeland, S., Banchereau, J., Mannoni, P. & Klein, B. (1990) Granulocyte macrophage stimulating factor synergizes with interleukin 6 in supporting the proliferation of human myeloma cells. Blood, 76, 2599-2605.
44. Zhang, X., Gaillard, J.P., Robillard, N., Lu, Z., Gu, Z.L., Jourdan, M., Boiron, J.M., Bataille, R. & Klein, B. (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood, 83, 3654-3663.
45. Zhang, X.G., Klein, B. & Bataille, R. (1989) Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. Blood, 74, 11-13.